Physician

Natalie Anne Stanton, M.D.

According to 2025 Medicare claims, Natalie Stanton, M.D. (NPI: 1528230737) practices hematology/oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC (NPI: 1093370918; TIN: 834425637) and primary practice location at 85716-1729. Stanton is affiliated with the ABC Network (ACO ID: A5554), participating under the MSSP model.

Stanton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 509 traditional Medicare patients, billed 157,228 HCPCS/CPT codes, and received $2,661,947 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,393 prescription claims across 218 beneficiaries totaling $3,335,202 in drug costs, led by Revlimid (Lenalidomide). DME data shows 52 claims. Open Payments data shows 80 records totaling $1,729. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,274,940 to $2,661,947. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $625,438 to $3,335,202. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $1,274,940 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,445,378 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,477,260 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,570,770 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,059,399 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,308,250 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,765,307 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,676,956 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,560,140 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,661,947 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201531883,607$1,274,940
2016370125,972$1,445,378
2017430118,422$1,477,260
2018475189,144$2,570,770
2019412121,452$2,059,399
2020334216,190$2,308,250
2021340159,768$1,765,307
2022554194,445$2,676,956
2023497163,675$2,560,140
2024509157,228$2,661,947

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.3M2015 Drug cost: $625,438 (USD; Tot_Drug_Cst)2016 Drug cost: $897,128 (USD; Tot_Drug_Cst)2017 Drug cost: $1,356,299 (USD; Tot_Drug_Cst)2018 Drug cost: $1,725,598 (USD; Tot_Drug_Cst)2019 Drug cost: $1,786,842 (USD; Tot_Drug_Cst)2020 Drug cost: $1,746,746 (USD; Tot_Drug_Cst)2021 Drug cost: $1,787,759 (USD; Tot_Drug_Cst)2022 Drug cost: $2,530,173 (USD; Tot_Drug_Cst)2023 Drug cost: $2,849,545 (USD; Tot_Drug_Cst)2024 Drug cost: $3,335,202 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015140920$625,438
20161531,309$897,128
20171561,404$1,356,299
20181911,502$1,725,598
20191711,060$1,786,842
20201461,162$1,746,746
20211591,049$1,787,759
20222001,354$2,530,173
20232001,414$2,849,545
20242181,393$3,335,202

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$22K$45K2015 Medicare payment: $44,620 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $34,301 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $18,183 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $5,398 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $7,631 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,615 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $6,609 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $876 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $9,429 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $4,552 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R150$44,620
2016N/R97$34,301
2017N/R55$18,183
2018N/R31$5,398
2019N/R64$7,631
2020N/R36$3,615
2021N/R77$6,609
2022N/R11$876
2023N/R31$9,429
2024N/R52$4,552

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more7575$111
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more97349$97
96413Administration of chemotherapy into vein, 1 hour or less61316$97
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more300646$63
96372Injection of drug or substance under skin or into muscle99326$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide40931$600,799
CalquenceAcalabrutinib Maleate24720$338,526
JakafiRuxolitinib Phosphate18540$270,610
ImbruvicaIbrutinib14392$229,587
TagrissoOsimertinib Mesylate12360$206,973

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
B4152Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unitNN/R13$2,811
B4034Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tapeNN/R13$961
J8521Capecitabine, oral, 500 mgNN/R13$534
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R13$245

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.80$1,729AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Natalie Anne Stanton, M.D.?

Tedicare shows public-source Medicare data for Natalie Anne Stanton, M.D. (NPI 1528230737), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Natalie Anne Stanton, M.D. have ACO affiliation data?

Natalie Anne Stanton, M.D. is shown with ACO affiliation data for ABC Network (MSSP, ACO ID A5554).

What billing organization is linked to Natalie Anne Stanton, M.D.?

Natalie Anne Stanton, M.D. is linked to ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC (billing NPI 1093370918) in the available physician profile data.

Does Natalie Anne Stanton, M.D. have Open Payments data?

Natalie Anne Stanton, M.D. has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.